Literature DB >> 34119349

Willingness to get vaccinated against Covid-19 and attitudes toward vaccination in general.

Roselinde Kessels1, Jeroen Luyten2, Sandy Tubeuf3.   

Abstract

BACKGROUND: High uptake of Covid-19 vaccination is required to reach herd immunity.
METHODS: A representative sample of 2,060 Belgians were surveyed in October 2020. Regression analyses identified the predictors associated with willingness to get vaccinated against Covid-19, and attitudes toward vaccination in general.
RESULTS: 34% of the participants reported that they will definitely get vaccinated against Covid-19 and 39% that they would "probably". Intended uptake was strongly associated with age, opinion on the government's dealing with the Covid-19 pandemic, medical risk, spoken language, gender, and to a lesser extent with having known someone who was hospitalised because of Covid-19. Similar predictors were identified for attitudes to vaccination in general. Covid-19 vaccine hesitancy was more marked in age groups below 54 years old. We further analysed a sample of 17% (N = 349) found favourable to vaccination in general but not willing to be vaccinated against Covid-19. They were mainly female, young, French speaking, slightly less educated, working, and did not belong to a Covid-19 risk group. They were very dissatisfied with the government's dealing with the pandemic, and did not know someone who was hospitalised because of Covid-19.
CONCLUSIONS: Vaccine hesitancy was higher for Covid-19 vaccines than for other vaccines. The part of the population being convinced of the utility of vaccination in general but hesitant about the Covid-19 vaccine is a primary interest group for tailored communication campaigns in order to reach the vaccine coverage needed for herd immunity.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Belgium; Covid-19; Hesitancy; Immunisation; Vaccination

Year:  2021        PMID: 34119349      PMCID: PMC8149196          DOI: 10.1016/j.vaccine.2021.05.069

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


Introduction

After months of a global public health crisis that has paralysed our societies, safe and effective vaccines that protect against Covid-19 are becoming available [1], [2]. The next crucial challenge will be to deploy these vaccines with sufficiently high vaccination coverage rates in the population so that thresholds required for herd immunity can be reached. For vaccine efficacies of approximately 80%, it has been estimated that herd immunity requires that minimally 60% but possibly up to 90% of the population become vaccinated [3], [4]. Herd immunity will not just be a bonus that comes on top of individual vaccine protection; it will be an essential layer of Covid-19 prevention on which many people will depend as it remains to be seen whether Covid-19 vaccines will be equally effective in all individuals and whether some population subgroups won’t be able to receive vaccination for medical reasons. To rapidly achieve herd immunity, mass vaccination will be required. However, apart from the logistic challenge of reaching sufficient numbers of individuals, there is an even bigger challenge in convincing vaccine hesitant individuals to become vaccinated [5]. Vaccination has always been controversial and throughout history a part of the population has always resisted it [6]. Over the past years, researchers have observed substantial and increasing levels of vaccine hesitancy in the population, often linked to the fact that infectious diseases and their consequences are fading from public memory but also in part through misinformation propagated on the internet [7], [8]. The World Health Organization (WHO) labelled vaccine hesitancy one of the top ten threats to global health in 2019, next to e.g. antimicrobial resistance or air pollution and climate change [9]. In the context of the Covid-19 vaccine, policy makers dealing with vaccine hesitancy and scepticism will be a critical success factor. Therefore, it is important that policy makers have a good view on the people profiles who are likely to refuse or delay vaccination. This will enable them to target communication campaigns and to devise vaccination strategies that take into account the clustering of susceptibility in profiles that are likely to refuse. Several population surveys have identified predictors associated with Covid-19 vaccine hesitancy. It is more likely to occur in individuals of younger age, women as well as people with lower income, lower education, lower perceived severity of Covid-19, lower Covid-19 exposure, lower trust in government, living in more disadvantaged areas or people adhering to more right-wing political views [10], [11], [12], [13], [14]. This paper aims to identify among a representative sample of the Belgian population the predictors associated with the willingness to become vaccinated against Covid-19 and investigate whether these coincide with predictors of attitudes toward vaccination in general.

Methods

Survey

We used a nationally representative panel of the market research agency Dynata to complete a survey between 6 and 16 October 2020‡ . A sample of 2,698 respondents drawn from a panel of 5,500 selected members who mirror the Belgian population (aged 18–80 years) as well as possible§ , were invited to participate in the survey. Of these, 494 did not complete the survey and 144 were excluded because they did not meet the company’s internal quality controls (e.g., they completed the survey unreasonably fast (below a third of the median time to completion)). This left us with a sample of 2,060 responses, which fulfilled pre-determined Belgium quota for age, gender and province (Appendix A). The main objective of the survey was to carry out an experiment to elicit individual preferences on who should get vaccinated first in the population; the results of the experiment are reported elsewhere [15]. In this paper we focus on two specific questions about attitudes toward vaccination. Before participants took the experiment, we asked them to answer the question “Would you say that vaccination for infectious disease is… very useful, rather useful, rather useless, very useless”. Then, at the end of the experiment, we asked the question “Once there is a safe and effective Covid-19 vaccine, will you get vaccinated?” and the four response items were “definitely”, “probably”, “probably not”, “definitely not”. The survey started by asking respondents for a range of sociodemographic characteristics along with their attitudes toward the government’s dealing with the corona crisis, whether they had had Covid-19, whether someone they knew had had it, was hospitalised because of it and had died because of it. Respondents were also asked whether their profession was among the “essential professions” (i.e., those that were obliged to keep working during the first “lockdown” in March/April 2020) and whether they considered themselves to be part of a risk group for Covid-19 and if so, which group they belonged to (old age, chronic illness, obesity, or other). Finally, respondents were asked about whom should decide who gets the Covid-19 vaccine first (government, scientists or the population) and whether they would choose to be vaccinated themselves once a vaccine becomes available.

Data analysis

We considered willingness to get Covid-19 vaccinated as a binary variable grouping the answers “definitely” against “probably”, “probably not” and “definitely not”. We determined the factors significantly associated to this response using a multivariate logistic regression model with as dependent variable whether an individual intends to become vaccinated or still doubts or refuses to become vaccinated. We estimated adjusted and unadjusted odds ratios of willingness to be Covid-19 vaccinated using all the variables that showed significance (p < 0.05) in a univariate analysis. We repeated the same analysis for attitudes toward infectious disease vaccination grouping “very useful” against “rather useful”, “rather useless” and “very useless”. We then studied the sub-sample of people who exhibited a seemingly inconsistent opinion of being pro-vaccination in general but being unwilling to take the Covid-19 vaccine once available. We used basic descriptive statistics and frequencies to describe all variables, comparing the full sample of survey data with the smaller sample of inconsistent individuals. We used chi-square tests to indicate significant differences in proportions between the two samples. We performed all analyses using the JMP Pro 16 statistical software.

Results

A total of N = 2,060 surveys were completed and checked for quality based on respondents’ answers to several comment boxes. None were excluded. Overall, 34% (N = 651) indicated that they would “definitely” become vaccinated with a Covid-19 vaccine and 39% (N = 742) stated that they would “probably” become vaccinated with a Covid-19 vaccine, 18% (N = 346) said “probably not” and 9% (N = 165) said “definitely not”. The numbers of sceptical answers to Covid-19 vaccination were substantially higher than the sceptical answers to the usefulness of vaccination in general. Whereas 73% stated to be willing to become vaccinated with the Covid-19 vaccine, 90% stated to think that vaccination is useful to protect against infectious diseases. 49% (N = 1,002) stated that vaccination is “very useful” and 41% (N = 848) stated it to be “rather useful”. 7% (N = 153) said “rather useless” and 3% (N = 57) said “very useless”. When carrying out univariate analyses, we found larger discrepancies in different age groups’ willingness to be Covid-19 vaccinated compared to their attitude toward vaccination in general. While at most 12.7% of the population across all age groups found vaccination rather or very useless (See Fig. 1 ), Covid-19 vaccine scepticism represented between 30% and 36% among people younger than 54 years old with the largest share of sceptics in the 25–34 and 35–44 age groups (See Fig. 2 ). While there were fewer Covid-19 vaccine sceptics in the older age groups (20% in 55–64 and 13.3% in people above 65), these shares were still larger than the shares of people reporting vaccination in general to be useless across any age groups.
Fig. 1

Distribution of the attitudes toward the usefulness of infectious disease vaccination according to age groups.

Fig. 2

Distribution of the willingness to be Covid-19 vaccinated according to age groups.

Distribution of the attitudes toward the usefulness of infectious disease vaccination according to age groups. Distribution of the willingness to be Covid-19 vaccinated according to age groups. The multivariate logistic regression analyses (Table 1 ) revealed that factors predicting willingness to vaccinate against Covid-19 were being male (Odds Ratio (OR) = 1.53, (95% confidence interval 1.25–1.89), p < 0.0001), being Dutch-speaker (OR = 2.37 (1.89–2.95), p < 0.0001), knowing someone who was hospitalised for Covid-19 (OR = 1.78 (1.16–2.71), p = 0.0083), and belonging to a medically vulnerable group (OR = 1.71 (1.35–2.17), p < 0.0001). The willingness to get Covid-19 vaccinated also gradually increased with age groups from age 45 when compared to the younger age category of 18–24 (45–54 OR = 1.16 (0.75–1.77), 55–64 OR = 1.72 (1.11–2.66), 65 and above OR = 2.26 (1.45–3.53), p < 0.0001) and with satisfaction toward the government’s response to the health crisis (satisfied OR = 2.94 (1.61–5.37), rather satisfied OR = 1.55 (1.15–2.10), rather dissatisfied OR = 1.17 (0.87–1.58), p = 0.0003). When asked about who should decide about priority access to the Covid-19 vaccine, people willing to get vaccinated were more likely to reply government or scientists (respectively OR = 1.58 (1.00–2.51), OR = 2.14 (1.50–3.06), p < 0.0001) versus the population.
Table 1

Unadjusted and adjusted odds ratios of willingness to get Covid-19 vaccinated and of having a non-hesitant attitude toward vaccination in general.

CharacteristicCovid-19 vaccine acceptance
General vaccine acceptance
Unadjusted odds ratio (95% CI)Adjusted odds ratio (95% CI)P-value (adjusted)Unadjusted odds ratio (95% CI)Adjusted odds ratio (95% CI)P-value (adjusted)
Gender
Male1.55 (1.28–1.87)1.53 (1.25–1.89)<0.00011.26 (1.06–1.50)1.32 (1.08–1.61)0.0058
Language
Dutch2.33 (1.90–2.85)2.37 (1.89–2.95)<0.00011.68 (1.41–2.00)1.54 (1.25–1.90)<0.0001
Age
18–241.00 (reference)1.00 (reference)<0.00011.00 (reference)1.00 (reference)<0.0001
25–340.73 (0.47–1.13)0.69 (0.44–1.09)1.19 (0.83–1.70)1.28 (0.86–1.91)
35–441.00 (0.66–1.52)0.95 (0.61–1.47)1.21 (0.85–1.72)1.29 (0.86–1.93)
45–541.30 (0.87–1.95)1.16 (0.75–1.77)1.54 (1.09–2.18)1.59 (1.07–2.36)
55–642.02 (1.35–3.03)1.72 (1.11–2.66)2.31 (1.62–3.30)2.31 (1.53–3.49)
65–803.48 (2.35–5.16)2.26 (1.45–3.53)3.27 (2.31–4.64)2.45 (1.59–3.76)
Education
Basic1.00 (reference)1.00 (reference)0.17051.00 (reference)1.00 (reference)0.0002
Third degree sec school1.18 (0.93–1.51)1.11 (0.84–1.45)1.31 (1.05–1.64)1.35 (1.04–1.75)
Higher1.09 (0.85–1.38)1.28 (0.98–1.68)1.52 (1.22–1.90)1.71 (1.32–2.22)
Have children
Yes1.22 (1.00–1.49)NS1.30 (1.09–1.56)NS
Profession
Working1.00 (reference)NS1.00 (reference)NS
Homemaker0.97 (0.58–1.62)1.05 (0.68–1.63)
Student0.98 (0.66–1.46)0.76 (0.54–1.06)
Unemployed1.02 (0.68–1.54)1.01 (0.70–1.44)
Disabled1.87 (1.27–2.76)1.04 (0.72–1.50)
Retired2.93 (2.33–3.69)2.06 (1.66–2.57)
Profession is not 'essential'
Yes1.40 (1.09–1.81)NS1.24 (1.00–1.55)NS
Financial difficulties
Never1.41 (1.08–1.86)NS1.84 (1.43–2.36)1.33 (1.00–1.79)0.1095
Once a year1.04 (0.77–1.42)1.27 (0.96–1.69)1.09 (0.79–1.50)
Once every three months0.89 (0.65–1.23)1.08 (0.81–1.44)1.01 (0.73–1.39)
Every month1.00 (reference)1.00 (reference)1.00 (reference)
Satisfaction with government’s approach to Covid-19 pandemic
Very satisfied3.69 (2.12–6.43)2.94 (1.61–5.37)0.00035.28 (2.87–9.71)4.14 (2.13–8.04)<0.0001
Rather satisfied1.66 (1.26–2.19)1.55 (1.15–2.10)1.74 (1.36–2.23)1.53 (1.16–2.04)
Rather dissatisfied1.23 (0.94–1.63)1.17 (0.87–1.58)1.37 (1.07–1.75)1.24 (0.94–1.64)
Very dissatisfied1.00 (reference)1.00 (reference)1.00 (reference)1.00 (reference)
Has had a Covid-19 infection
Yes, confirmed with a test1.34 (0.70–2.54)NS1.60 (0.90–2.86)1.07 (0.56–2.05)0.1145
Probably, but not confirmed1.00 (reference)1.00 (reference)1.00 (reference)
with a testNo1.43 (0.99–2.06)1.47 (1.07–2.02)1.45 (1.00–2.12)
Know personally someone who has had Covid-19
Yes, confirmed with a test1.35 (0.90–2.04)NS1.31 (0.91–1.88)1.13 (0.74–1.71)0.0036
Probably, but not confirmed with a test1.00 (reference)1.00 (reference)1.00 (reference)
No1.28 (0.90–1.82)1.06 (0.78–1.44)0.71 (0.49–1.04)
Know personally someone who was hospitalised for Covid-19
Yes1.60 (1.09–2.35)1.78 (1.16–2.71)0.00831.04 (0.73–1.49)NS
Know personally someone who died of Covid-19
Yes1.31 (0.85–2.04)NS1.21 (0.80–1.85)NS
Belong to a medically vulnerable group
Yes2.61 (2.15–3.18)1.71 (1.35–2.17)<0.00012.34 (1.95–2.81)1.83 (1.45–2.30)<0.0001
Determination vaccine prioritisation
Population1.00 (reference)1.00 (reference)<0.00011.00 (reference)1.00 (reference)<0.0001
Government2.35 (1.53–3.60)1.58 (1.00–2.51)2.84 (1.90–4.23)1.94 (1.26–2.97)
Scientists2.30 (1.64–3.20)2.14 (1.50–3.06)2.84 (2.10–3.85)2.57 (1.86–3.55)
Covid-19 vaccine acceptance
Yes, sure16.44 (12.72–21.24)
General vaccine acceptance
Very useful16.44 (12.72–21.24)

Note: NS stands for “highly non-significant” (p-value > 0.2).

Unadjusted and adjusted odds ratios of willingness to get Covid-19 vaccinated and of having a non-hesitant attitude toward vaccination in general. Note: NS stands for “highly non-significant” (p-value > 0.2). The predicting factors of the willingness to get vaccinated against Covid-19 were mostly similar to the predicting factors of reporting that infectious disease vaccination is very useful as illustrated by the strong correlation with the very high odds ratio of being both willing to take the Covid-19 vaccine and finding infectious disease vaccination very useful (OR = 16.44 (12.72–21.24)). While socioeconomic characteristics were not identified as predictors of the willingness to vaccinate against Covid-19, educational attainment is significantly and increasingly associated with positive opinion about vaccination in general (compared to basic education, secondary school OR = 1.35 (1.04–1.75), higher education OR = 1.71 (1.32–2.22), p = 0.0002). While most respondents finding vaccination very or rather useful were favourable to Covid-19 vaccination (71.3%), a sample of N = 349 individuals (18.3%) exhibited a remarkable opinion toward vaccination ( Fig. 3 ). They considered vaccination against infectious diseases very useful (15%, N = 52) or rather useful (85%, N = 297), but reported they would definitely not (24%, N = 85) or rather not (76%, N = 264) vaccinate against Covid-19. As these are likely to be the people in which communication campaigns about safety and effectiveness of Covid-19 vaccines are most effective, we investigated further who those people were (Table 2 ). Compared to the main sample, they were more likely to be women (p = 0.0067), younger than 54 years old (p < 0.0001), French speaking (p < 0.0001), with first or second degree secondary school (p = 0.0714), and working (p < 0.0001). They were also less likely to belong to a Covid-19 risk group (p < 0.0001), to have known someone who was hospitalised because of Covid-19 (p = 0.0314), and they were rather or very dissatisfied with the government’s dealing with the Covid-19 crisis (p < 0.0001). A sample of N = 36 individuals (1.9%) presented however negative attitudes toward vaccination in general but were willing to get vaccinated against Covid-19. They would get the Covid-19 vaccine for sure (0.4%, N = 8) or probably (1.5%, N = 28), but reported they find vaccination against infectious diseases very useless (0.7%, N = 13) or rather useless (1.2%, N = 23). Compared to the main sample, they were more likely to be men (p = 0.0046) who had not had a Covid-19 infection (p = 0.0546) or had not known someone with a Covid-19 infection (p = 0.0463), neither had they known someone who had been hospitalised (p = 0.0331) or had died (p = 0.0710) because of Covid-19.
Fig. 3

Attitudes toward the usefulness of infectious disease vaccination and the willingness to be Covid-19 vaccinated.

Table 2

Descriptive statistics of the full sample and the subsample of contradictory respondents who believe vaccination is useful, but who do not wish to become vaccinated against Covid-19.

CharacteristicResponseitemFull sample (N = 2,060)
Subsample (N = 349)
P-value of difference$
N%N%
Respondents’ general background
GenderFemale105551%20659%p = 0.0067
Male100549%14341%
Age18–2420810%4112%p < 0.0001
25–3434617%7622%
35–4435817%8324%
45–5440019%7922%
55–6434117%3811%
65–8040720%329%
LanguageDutch117457%15645%p < 0.0001
French88643%19355%
EducationNone80%00%p = 0.0714
Primary school653%62%
First degree secondary school20810%4312%
Second degree secondary school26213%5315%
Third degree secondary school71535%12035%
Higher education (non-university)49524%8123%
University or post-university education27814%4513%
PhD211%00%
Other80%10%
Have childrenYes128362%20860%p = 0.3414
No77738%14140%
ProfessionWorking103951%21662%p < 0.0001
Homemaker874%144%
Student1688%288%
Unemployed1387%308%
Disabled1316%206%
Retired49724%4112%
Difficulties with monthly expensesNever84741%12435%p = 0.2371
Once a year44722%7923%
Once every three months41320%7722%
Every month35317%6920%



Respondents’ Covid-19 related background
Self-reported membership of a Covid-19 risk groupNo126161%26576%p < 0.0001
Yes, elderly38419%288%
Yes, chronically ill42421%5215%
Yes, severe obesity1336%144%
Yes, other693%62%
Self-reported profession is labelled as 'essential'Yes39319%7421%p = 0.3575
No166781%27579%
Has had a Covid-19 infectionYes, confirmed with a test643%82%p = 0.4110
Probably, but not confirmed with a test1738%247%
No182389%31791%
Know personally someone who has had Covid-19Yes, confirmed with a test31415%4914%p = 0.7480
Probably, but not confirmed with a test1879%3510%
No155976%26576%
Know personally someone who was hospitalised for Covid-19Yes1276%123%p = 0.0314
No193394%33797%
Know personally someone who died of Covid-19Yes924%134%p = 0.5222
No196896%33696%
Satisfaction with government’s approach to Covid-19 pandemicVery satisfied663%21%p < 0.0001
Rather satisfied77438%9226%
Rather dissatisfied82740%15845%
Very dissatisfied39319%9728%
Determination of the vaccine prioritization strategyPopulation24213%5817%p = 0.1030
Government19610%298%
Scientists146677%26275%

Chi-square test to indicate significant differences in proportions between the two samples.

Attitudes toward the usefulness of infectious disease vaccination and the willingness to be Covid-19 vaccinated. Descriptive statistics of the full sample and the subsample of contradictory respondents who believe vaccination is useful, but who do not wish to become vaccinated against Covid-19. Chi-square test to indicate significant differences in proportions between the two samples.

Discussion

A majority of Belgians (73%) report that they will definitely or probably get vaccinated against Covid-19, though uptake is predicted to be lower among younger individuals, people at lower risk of severe forms of Covid-19, women, those with lower education, and those with lower trust in authorities. These characteristics have also been identified as predictors of Covid-19 vaccine hesitancy in similar studies in other countries [10], [11], [12], [13], [14]. According to Anderson et al. (2020) [3], if a vaccine has approximately 80% efficacy, it is between 70% and 90% of the population who needs to be vaccinated. If this is the case, the observed share of the population willing to get Covid-19 vaccinated in this representative sample may not be sufficient. However, a sample of 17% of the population was found to be in favour of vaccination in general but hesitant toward Covid-19 vaccination and so, this hesitant group may be a key factor in whether herd immunity against the coronavirus can be achieved within the population. Our study suggests that, rather than focussing on vaccine sceptics or antivaxxers who will be harder to convince that Covid-19 vaccination is necessary, communication and educational efforts should be mainly targeted at the group we identified as being pro-vaccines but doubtful about the specific Covid-19 vaccine. A limitation of this survey is that it did not collect reasons for Covid-19 vaccine hesitancy to study further the sample of contradictory individuals who consider vaccination useful, but do not wish to get vaccinated against Covid-19. Why are people hesitant? Some of the many reasons behind vaccine hesitancy are related to the success of vaccines to eradicate diseases that used to be deathly and as a result, people focus on the perceived risks of vaccination because they are less aware of the consequences of not vaccinating [5], [16]. In the context of Covid-19, we show that vaccine hesitancy may also be caused by individuals having no personal experience with people in their proximity having been critically ill or passing away as a result of Covid-19 [17] because the willingness to get vaccinated is almost twice higher when knowing someone who has been hospitalised because of Covid-19. However, there is hesitancy toward the Covid-19 vaccine beyond a clear support for the usefulness of vaccination against infectious diseases. This Covid-19 hesitant group differs from anti-vax profiles. Their hesitancy might therefore be explained by particular concerns about the Covid-19 vaccine, e.g., that it has been developed too fast, that the full safety profile of the vaccine is not (yet) entirely understood or where it was manufactured as shown in other studies [12], [13], [14], [18], [19]. To conclude, our study found that a larger than usual share of the general public may prefer not to vaccinate against Covid-19 and this suggests that many feel they cannot make a fully informed vaccination decision. This calls for communication campaigns that comfort people on the safety and efficacy of Covid-19 vaccination, particularly in the hesitant subgroup that is nonetheless pro-vaccination in general.

Ethics committee approval

This study did not fall under the Belgian law on experiments as anonymised data collected by a third party were analysed and therefore the Social and Societal Ethics Committee (SMEC) of KU Leuven decided that no approval was needed.

Role of funding source

No funding sources to declare. Roselinde Kessels acknowledges her Elinor Ostrom research grant from Maastricht University which was used to collect part of the data. Also, she thanks the JMP Division of SAS Institute for further financial support.

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
VariablesCategoriesStudy sampleBelgian population§
GenderFemale51%51%
Male49%49%
Age18–2410%11%
25–3417%16%
35–4417%17%
45–5419%18%
55–6417%16%
65–8020%22%
LanguageDutch57%60%
French43%40%
ProvinceVlaams-Brabant10%10%
Waals-Brabant7%3%
Brussels Capital9%10%
Antwerpen15%16%
Limburg8%8%
East Flanders13%13%
West Flanders10%11%
Hainaut6%12%
Liège10%10%
Luxembourg5%3%
Namur8%4%
EducationNone or primary school26%34%
Secondary school35%37%
Higher education39%29%

Source: Statbel

  15 in total

1.  Assessing vaccine hesitancy in the UK population using a generalized vaccine hesitancy survey instrument.

Authors:  Jeroen Luyten; Luk Bruyneel; Albert Jan van Hoek
Journal:  Vaccine       Date:  2019-03-30       Impact factor: 3.641

2.  Vaccine Hesitancy, History, and Human Nature: The 2018 Stanley A. Plotkin Lecture.

Authors:  Gary S Marshall
Journal:  J Pediatric Infect Dis Soc       Date:  2019-03-28       Impact factor: 3.164

3.  Fair Allocation of Scarce Medical Resources in the Time of Covid-19.

Authors:  Ezekiel J Emanuel; Govind Persad; Ross Upshur; Beatriz Thome; Michael Parker; Aaron Glickman; Cathy Zhang; Connor Boyle; Maxwell Smith; James P Phillips
Journal:  N Engl J Med       Date:  2020-03-23       Impact factor: 91.245

4.  Countering antivaccination attitudes.

Authors:  Zachary Horne; Derek Powell; John E Hummel; Keith J Holyoak
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-03       Impact factor: 11.205

5.  What policy makers need to know about COVID-19 protective immunity.

Authors:  Daniel M Altmann; Daniel C Douek; Rosemary J Boyton
Journal:  Lancet       Date:  2020-04-27       Impact factor: 79.321

6.  Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.

Authors:  Fernando P Polack; Stephen J Thomas; Nicholas Kitchin; Judith Absalon; Alejandra Gurtman; Stephen Lockhart; John L Perez; Gonzalo Pérez Marc; Edson D Moreira; Cristiano Zerbini; Ruth Bailey; Kena A Swanson; Satrajit Roychoudhury; Kenneth Koury; Ping Li; Warren V Kalina; David Cooper; Robert W Frenck; Laura L Hammitt; Özlem Türeci; Haylene Nell; Axel Schaefer; Serhat Ünal; Dina B Tresnan; Susan Mather; Philip R Dormitzer; Uğur Şahin; Kathrin U Jansen; William C Gruber
Journal:  N Engl J Med       Date:  2020-12-10       Impact factor: 91.245

7.  COVID-19 vaccine hesitancy in the UK: the Oxford coronavirus explanations, attitudes, and narratives survey (Oceans) II.

Authors:  Daniel Freeman; Bao S Loe; Andrew Chadwick; Cristian Vaccari; Felicity Waite; Laina Rosebrock; Lucy Jenner; Ariane Petit; Stephan Lewandowsky; Samantha Vanderslott; Stefania Innocenti; Michael Larkin; Alberto Giubilini; Ly-Mee Yu; Helen McShane; Andrew J Pollard; Sinéad Lambe
Journal:  Psychol Med       Date:  2020-12-11       Impact factor: 7.723

8.  COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics.

Authors:  Michaël Schwarzinger; Verity Watson; Pierre Arwidson; François Alla; Stéphane Luchini
Journal:  Lancet Public Health       Date:  2021-02-06

9.  COVID-19 vaccine hesitancy and resistance: Correlates in a nationally representative longitudinal survey of the Australian population.

Authors:  Ben Edwards; Nicholas Biddle; Matthew Gray; Kate Sollis
Journal:  PLoS One       Date:  2021-03-24       Impact factor: 3.240

10.  COVID-19 Vaccination Hesitancy in the United States: A Rapid National Assessment.

Authors:  Jagdish Khubchandani; Sushil Sharma; James H Price; Michael J Wiblishauser; Manoj Sharma; Fern J Webb
Journal:  J Community Health       Date:  2021-01-03
View more
  20 in total

1.  "When did you decide to receive the Covid-19 vaccine?" Survey in a high-volume vaccination center.

Authors:  Marion Le Maréchal; Amina Batel; Stéphanie Bouvier; Hajer Mahdhaoui; Morgane Margotton; Jean-Philippe Vittoz; Etienne Brudieu; Christine Chevallier; Pierrick Bedouch; Saber Touati; Olivier Epaulard
Journal:  Hum Vaccin Immunother       Date:  2022-01-18       Impact factor: 3.452

2.  The roles of experiences and risk perception in the practice of preventative behaviors of COVID-19.

Authors:  Tina Fadel; Justin Travis; Scott Harris; Ginny Webb
Journal:  Pathog Glob Health       Date:  2021-07-27       Impact factor: 3.735

3.  Vaccine Hesitancy towards the COVID-19 Vaccine in a Random National Sample of Belgian Nursing Home Staff Members.

Authors:  Marina Digregorio; Pauline Van Ngoc; Simon Delogne; Eline Meyers; Ellen Deschepper; Els Duysburgh; Liselore De Rop; Tine De Burghgraeve; Anja Coen; Nele De Clercq; An De Sutter; Jan Y Verbakel; Piet Cools; Stefan Heytens; Laëtitia Buret; Beatrice Scholtes
Journal:  Vaccines (Basel)       Date:  2022-04-12

4.  Attitudes, acceptance and hesitancy among the general population worldwide to receive the COVID-19 vaccines and their contributing factors: A systematic review.

Authors:  Fidelia Cascini; Ana Pantovic; Yazan Al-Ajlouni; Giovanna Failla; Walter Ricciardi
Journal:  EClinicalMedicine       Date:  2021-09-02

5.  COVID-19 Vaccine Acceptance among ASEAN Countries: Does the Pandemic Severity Really Matter?

Authors:  An Hoai Duong; Ernoiz Antriyandarti
Journal:  Vaccines (Basel)       Date:  2022-01-30

6.  Social media use and vaccine hesitancy in the European Union.

Authors:  Massimiliano Mascherini; Sanna Nivakoski
Journal:  Vaccine       Date:  2022-03-03       Impact factor: 4.169

7.  Intention to Receive the COVID-19 Vaccine Booster Dose in a University Community in Italy.

Authors:  Lucio Folcarelli; Grazia Miraglia Del Giudice; Francesco Corea; Italo F Angelillo
Journal:  Vaccines (Basel)       Date:  2022-01-19

Review 8.  A Global Map of COVID-19 Vaccine Acceptance Rates per Country: An Updated Concise Narrative Review.

Authors:  Malik Sallam; Mariam Al-Sanafi; Mohammed Sallam
Journal:  J Multidiscip Healthc       Date:  2022-01-11

9.  Characteristics Associated with the Dual Behavior of Mask Wearing and Vaccine Acceptance: A Pooled Cross-Sectional Study among Adults in Saskatchewan.

Authors:  Ali Bukhari; Daniel A Adeyinka; Jessica McCutcheon; Natalie Kallio; Nazeem Muhajarine
Journal:  Int J Environ Res Public Health       Date:  2022-03-09       Impact factor: 3.390

10.  Characteristics of the Third COVID-19 Pandemic Wave with Special Focus on Socioeconomic Inequalities in Morbidity, Mortality and the Uptake of COVID-19 Vaccination in Hungary.

Authors:  Beatrix Oroszi; Attila Juhász; Csilla Nagy; Judit Krisztina Horváth; Krisztina Eszter Komlós; Gergő Túri; Martin McKee; Róza Ádány
Journal:  J Pers Med       Date:  2022-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.